Author

Agnieszka Nadzieja-Kozioł

Observed names: A Nadzieja-Koziol, A. Nadzieja-Kozioł

OpenAlex ID: A5083283387

Pbi31 Cost-effectiveness Comparison of Risankizumab and Ustekinumab for the Treatment of Severe Psoriasis

2019 · M. Dzik, A. Nadzieja-Kozioł, et al. · Value in Health · 1

PD208 Optimal Scheme For Molecular Diagnosis Of BRCA1/2 Gene Mutations In Patients With Breast Cancer In Poland - Cost-Utility Analysis

2024 · Paweł Książek, Maurycy Muzyka, et al. · International Journal of Technology Assessment in Health Care

PD209 Social Burden Of Inflammatory Bowel Diseases In Poland: Impact Of Changes In Drug Programs On Social Security Expenditures

2024 · Grzegorz Binowski, Dominik Strządała, et al. · International Journal of Technology Assessment in Health Care

Pms12 Tocilizumab in Moderate-to-severe Rheumatoid Arthritis: Systematic Review of Efficacy and Safety

2019 · A. Nadzieja-Kozioł, D. Leszczyńska, et al. · Value in Health

Prs1 a Comparison of Efficacy and Safety of Fluticasone With Budesonide and Beclomethasone in 1:2 Dose Ratio in the Treatement of Bronchial Asthma

2009 · O Pankiewicz, A Nadzieja-Koziol, et al. · Value in Health

Prs4 Indirect Comparison of Efficacy and Safety of Fluticasone and Budesonide in the Treatement of Chronic Obstructive Pulmonary Disease

2009 · O Pankiewicz, K Jagodzinska, et al. · Value in Health

Prs3 a Comparison of Efficacy of Fluticasone With Budesonide and Beclomethasone in 1:1 Dose Ratio in the Treatment of Bronchial Asthma

2009 · O Pankiewicz, A Nadzieja-Koziol, et al. · Value in Health

Pms3 a Comparison of Clinical Efficacy of Leflunomide Vs Other Therapuetic Options in the Treatement of Rheumatoid Arthritis

2008 · P Rys, K Kucia, et al. · Value in Health

Works count: 8

Citation count: 1

H-index: 1

I10-index: